Sarah Gillessen

2PUBLICATIONS
6CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 03, 2022
JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO).

Sarah Gillessen, Annette Pluetschow, Vladan Vucinic

|Nov 14, 2021
Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i).

Sarah Gillessen, Andreas Hüttmann, Vladan Vucinic

Pageof 1

Frequent Collaborators

1 joint publications

Andreas Hüttmann

1 joint publications

Boris Böll

1 joint publications

Dennis A Eichenauer

1 joint publications

Sven Borchmann